PRESS & NEWS
Study Recruitment: Treatment of Disturbed Sleep in PSP
This remote six-week study seeks to test the effects of two sleep medications.
This remote six-week study seeks to test the effects of two sleep medications.
You, or a family member, may fit the general eligibility criteria for the research study listed below. Please note:
Study Overview
This study is a remote, crossover design (everyone will receive two specific FDA approved sleeping medications and a placebo) clinical trial being run by Dr. Thomas Neylan at the University of California, San Francisco. It aims to test the effect of two sleep medications on the treatment of sleep disruption in Progressive Supranuclear Palsy (PSP) without the need of in-person visits to a study site.
Participants need to have a diagnosis of PSP and be based in California.
All participants will need a care partner who can help provide information about the patient during the interviews.
All standard study assessments will be done over the phone. The study lasts for six weeks, with at least one phone call every week.
Contact Information
For more information, please contact the study team:
Visit the study's website for more information and to see if you qualify.
Visit the FTD Disorders Registry Find A Study webpage for information on this and other study listings.
Together we can find a cure for ftd
The FTD Disorders Registry is a powerful tool in the movement to create therapies and find a cure. Together we can help change the course of the disease and put an end to FTD.
Your privacy is important! We promise to protect it. We will not share your contact information.